Belmont, MANCT05665491Now EnrollingIRB Ready

Anxiety Clinical Trial in Belmont, MA

Access cutting-edge anxiety treatment through this clinical trial at a research site in Belmont. Study-provided care at no cost to qualified participants.

Sponsored by Mclean Hospital

Quick Self-Assessment

See if you qualify for this Belmont location

Preparing your pre-screening questions…

Expert Care in Belmont

Access anxiety specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related anxiety treatment provided free

Apply for This Belmont Location

Check if you qualify for this anxiety clinical trial in Belmont, MA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Belmont

    Convenient for MA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Belmont site if eligible
  4. 4Begin participation

About This Anxiety Study in Belmont

Approximately 30% of children will experience an anxiety disorder, making anxiety the most common mental health problem among children in the United States. However, few children receive treatment and even our most effective anxiety treatments leave up to half of children in need of additional intervention. Despite the well-established role of parent anxiety in transmitting and maintaining child anxiety, the lack of data on specific parent mechanisms underlying the intergenerational transmission of anxiety is a critical barrier to informing novel targets of personalized treatments. Consistent with NIMH's Strategic Plan, Objective 2.2 to understand risk factors and behavioral indicators of mental illness across the lifespan and to identify novel intervention targets based on knowledge of psychological mechanisms, the current study focuses on interpretation bias, the tendency to perceive threat in ambiguous situations. The overall objective of this project is to empirically test a theoretical model of the intergenerational transmission of anxiety focused on parent interpretation bias as a root cause. Our specific aims are to test theorized effects of parent interpretation bias on (1) parent behavior and (2) child interpretation bias and (3) evaluate potential moderators to refine theories of intergenerational transmission of anxiety and inform future personalized interventions. Our central hypothesis is that parent interpretation bias influences child interpretation bias through its effects on maladaptive, anxiety-promoting parenting behaviors, such as accommodation and modeling of avoidant coping. To test this hypothesis, we will randomize 300 parents of children ages 7-12 to complete four weeks of a smartphone delivered interpretation bias manipulation vs. a self-assessment smartphone app condition. The interpretation bias intervention teaches parents to interpret ambiguous situations in a non-threatening manner via quick, repeated practice and corrective feedback. Before and after completing their randomly assigned condition, parent-child dyads will complete self-report and behavioral tasks designed to elicit anxiety-promoting behaviors from parents depending upon their interpretation of the ambiguous situation (speech and puzzle tasks). Parents will also complete Ecological Momentary Assessment (EMA) of parenting behaviors to capture the time course of effects. Finally, we will examine downstream effects of the interpretation manipulation on child interpretation bias at pre- and post- visits. We will test moderators (e.g., parent anxiety and gender) to refine theories of intergenerational transmission of anxiety and inform future personalized interventions. The long-term goal of this work is to inform personalized, mechanism-focused interventions to improve mental health outcomes for anxious children and their parents. Future studies will translate knowledge gained from this project into a scalable treatment that can be implemented entirely remotely via smartphone thereby increasing access to care

Sponsor: Mclean Hospital

Who Can Participate

Inclusion Criteria

for parent participants are:
Must have an ability to speak and understand English sufficiently to complete assessments
At least minimal anxiety severity (GAD-7 score \> 5)
At least a minimal level of interpretation bias (WSAP overall accuracy less than 70%)
No current psychiatric symptoms that would interfere with the individual's ability to provide consent or complete the research procedures
If receiving treatment, stable on medications or psychotherapy for 8 weeks
No severe suicidal ideation (PHQ-9 item 9 \> 1)
Own iOS or Android smartphone
Shared or full custody of child (for EMA assessment of parenting behaviors) Inclusion criteria for child participants are:
Age 7 to 12
Must have an ability to speak and understand English sufficiently to complete assessments
No diagnosis of intellectual disability or autism spectrum disorder (per parent or clinician report)
No current psychiatric symptoms that would prevent informed consent or understanding of research procedures
Wechsler Abbreviated Scale of Intelligence (WASI) full-scale IQ equal to or greater than 80 to ensure understanding of study procedures
If receiving treatment, stable on medications or psychotherapy for 8 weeks
No severe suicidal ideation (PHQ-9 item 9 \> 1)

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Belmont?

Yes, this clinical trial (NCT05665491) has an active research site in Belmont, MA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Anxiety Treatment Options in Belmont, MA

If you're searching for anxiety treatment options in Belmont, MA, this clinical trial (NCT05665491) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Belmont research site is actively enrolling participants for this clinical trial. You'll receive care from experienced anxiety specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all anxiety clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Belmont, MA

See all essential tremor clinical trials recruiting in Belmont — not just this study.

Browse Essential Tremor Trials in Belmont →

Ready to Join in Belmont?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Belmont, MA